Progress toward treatments for synaptic defects in autism.

Abstract : Autism spectrum disorder (ASD) encompasses a range of disorders that are characterized by social and communication deficits and repetitive behaviors. For the majority of affected individuals, the cause of ASD remains unknown, but in at least 20% of the cases, a genetic cause can be identified. There is currently no cure for ASD; however, results from mouse models indicate that some forms of the disorder could be alleviated even at the adult stage. Genes involved in ASD seem to converge on common pathways altering synaptic homeostasis. We propose, given the clinical heterogeneity of ASD, that specific 'synaptic clinical trials' should be designed and launched with the aim of establishing whether phenotype 'reversals' could also occur in humans.
Complete list of metadatas

Cited literature [78 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-01470299
Contributor : Elodie Ey <>
Submitted on : Tuesday, February 26, 2019 - 1:17:57 PM
Last modification on : Thursday, July 18, 2019 - 2:44:03 PM
Long-term archiving on : Monday, May 27, 2019 - 2:11:58 PM

File

Progress_treatments_autism.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Richard Delorme, Elodie Ey, Roberto Toro, Marion Leboyer, Christopher Gillberg, et al.. Progress toward treatments for synaptic defects in autism.. Nature Medicine, Nature Publishing Group, 2013, 19 (6), pp.685-94. ⟨10.1038/nm.3193⟩. ⟨pasteur-01470299⟩

Share

Metrics

Record views

447

Files downloads

178